Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Glutamine Isomers of Oxytocin and Deamino-oxytocin: Synthesis and Pharmacological Properties of [4-N4-Methyl-L-asparagine]-oxytocin and [1-β-Mercaptopropionic Acid, 4-N4-Methyl-L-asparagine]-oxytocin

R. T. HAVRAN, I. L. SCHWARTZ and RODERICH WALTER
Molecular Pharmacology January 1969, 5 (1) 83-89;
R. T. HAVRAN
The Mount Sinai Medical and Graduate Schools of The City University of New York, New York, New York 10029, and The Medical Research Center, Brookhaven National Laboratory, Upton, New York 11973
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. L. SCHWARTZ
The Mount Sinai Medical and Graduate Schools of The City University of New York, New York, New York 10029, and The Medical Research Center, Brookhaven National Laboratory, Upton, New York 11973
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RODERICH WALTER
The Mount Sinai Medical and Graduate Schools of The City University of New York, New York, New York 10029, and The Medical Research Center, Brookhaven National Laboratory, Upton, New York 11973
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Analogues of oxytocin and deamino-oxytocin ([1-β9-mercaptopropionic acid]-oxytocin) with an N4-methyl-L-asparagine residue in place of the glutamine residue in position 4 have been prepared and tested for their biological activities. [4-N4-Methyl-L-asparagine]-oxytocin was found to possess 119 ± 5 units/mg of avian vasodepressor activity, 41 ± 2 units/ mg of rat oxytocic activity, less than 0.5 unit/mg of rat pressor activity, and approximately 0.045 unit/mg of rat antidiuretic activity. The hydro-osmotic activity of the analogue was 2.23 ± 0.40% of that of crystalline deamino-oxytocin upon assay in the toad bladder system. The corresponding activity values for [1-β-mercaptopropionic acid,4-N4-methyl-L-asparagine]-oxytocin were 186 ± 4 units/mg, 59 ± 2 units/mg, less than 0.4 unit/mg, approximately 0.012 unit/mg, and 1.17 ± 0.11%, respectively. Most significantly, the replacement of the N-terminal amino group in [4-N4-methyl-L-asparagine]-oxytocin by hydrogen elicited not only a quantitative but even a qualitative alteration in the hydroosmotic activity.

ACKNOWLEDGMENTS The authors are indebted to the following members of this laboratory: Mr. L. Trauth for synthetic assistance; Mr. D. Schlesinger for amino acid analyses; and Miss M. Wahrenburg, Mrs. B. Dubois, Miss I. Bergman, Miss P. Walter, Mr. V. Sapirstein, and Mr. R. Felson for bioassays.

  • Copyright ©, 1969, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 5, Issue 1
1 Jan 1969
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Glutamine Isomers of Oxytocin and Deamino-oxytocin: Synthesis and Pharmacological Properties of [4-N4-Methyl-L-asparagine]-oxytocin and [1-β-Mercaptopropionic Acid, 4-N4-Methyl-L-asparagine]-oxytocin
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Glutamine Isomers of Oxytocin and Deamino-oxytocin: Synthesis and Pharmacological Properties of [4-N4-Methyl-L-asparagine]-oxytocin and [1-β-Mercaptopropionic Acid, 4-N4-Methyl-L-asparagine]-oxytocin

R. T. HAVRAN, I. L. SCHWARTZ and RODERICH WALTER
Molecular Pharmacology January 1, 1969, 5 (1) 83-89;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Glutamine Isomers of Oxytocin and Deamino-oxytocin: Synthesis and Pharmacological Properties of [4-N4-Methyl-L-asparagine]-oxytocin and [1-β-Mercaptopropionic Acid, 4-N4-Methyl-L-asparagine]-oxytocin

R. T. HAVRAN, I. L. SCHWARTZ and RODERICH WALTER
Molecular Pharmacology January 1, 1969, 5 (1) 83-89;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics